Does mismatch negativity have utility for NMDA receptor drug development in depression?
Braz J Psychiatry
; 44(1): 61-73, 2022.
Article
in En
| MEDLINE
| ID: mdl-33825765
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Depressive Disorder, Major
/
Ketamine
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Braz J Psychiatry
Journal subject:
PSIQUIATRIA
Year:
2022
Document type:
Article
Affiliation country:
United States
Country of publication:
Brazil